Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FC9S6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,215
Award facts
- Contract value 100% obligated
- $10,214.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,214.85 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitive award, which carries no set-aside designation, is issued under firm fixed pricing terms and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where the vendor maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. Dupixent is a specialty biologic medication used primarily for the treatment of atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, making this procurement part of the Defense Logistics Agency's broader effort to maintain an extensive inventory of specialty medications and brand-name pharmaceuticals to support Department of Defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FC9S6?
SPE2DB25FC9S6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FC9S6 worth?
The government has obligated $10,215 on SPE2DB25FC9S6.
Is contract SPE2DB25FC9S6 an order under another contract?
Yes. SPE2DB25FC9S6 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC9S6 competed?
The extent of competition for SPE2DB25FC9S6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award